3709 results for «200»
3709 results
New insights in coronary atherosclerosis using intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...
TAVI complications: the nurses and allied professionals' perspective
20 May 2026 – From EuroPCR 2026
This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.
Increasing efficiency in CTO PCI
21 May 2026 – From EuroPCR 2026
Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.
TAVI procedural complications - Part 6: paravalvular leak, basilica and more
20 May 2026 – From EuroPCR 2026
Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.
Imaging-guided CTO PCI
21 May 2026 – From EuroPCR 2026
This session focuses on imaging-guided CTO PCI, presenting cases that illustrate the utility of OCT, CT, and IVUS for lesion assessment and procedural guidance. Topics include woven-like CTOs, double CTO evaluation, management of late stent malapposition, and strategies for navigating complex occlusions to optimize outcomes.
Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
21 May 2026 – From EuroPCR 2026
This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...
Novel indications for DCB
21 May 2026 – From EuroPCR 2026
This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.
The structural bailout playbook: managing complications
21 May 2026 – From EuroPCR 2026
The session presents a practical structural bailout playbook focused on managing complex complications during structural heart interventions. It features challenging cases such as unusual atrial septal defect closure complications, navigation of a displaced patent ductus arteriosus stent in infants, percutaneous closure of mitral paravalvular leaks with...
TAVI in small annuli - Small anatomies, big challenges
21 May 2026 – From EuroPCR 2026
This session addresses the challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. It features registry data comparing valve types, evaluates long-term outcomes, prosthesis-patient mismatch implications, and regional variations in clinical and quality-of-life outcomes.
Revascularisation in patients with multivessel disease and severe left ventricular impairment
21 May 2026 – From EuroPCR 2026
This session focuses on revascularisation strategies for patients with multivessel coronary disease complicated by severe left ventricular impairment. It emphasizes patient selection criteria, the crucial role of the heart team in decision-making, and optimization of percutaneous revascularisation outcomes. The content includes comprehensive case presentations and discussions...
Physiological vs. anatomical assessment of multivessel disease patients
21 May 2026 – From EuroPCR 2026
This session delves into the comparative benefits of physiological versus anatomical assessment in patients with multivessel coronary disease, focusing particularly on myocardial infarction cases. Attendees will explore how coronary physiology can guide complete revascularisation, the added value of physiological assessment beyond conventional angiography, and the selection...
Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy
21 May 2026 – From EuroPCR 2026
This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...
Complex PCI - Best cases from PCR Global Interventional Academy - Part 2
21 May 2026 – From EuroPCR 2026
This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...
Refining PCI plannings and decision-making with novel technologies
21 May 2026 – From EuroPCR 2026
This session highlights cutting-edge technologies that enhance PCI planning and decision-making. It covers the clinical populations benefiting from QFR-guided revascularisation, prognostic insights from radial wall strain in DCB-treated vessels, and advances in artificial intelligence and machine learning to assess ischemia and predict PCI outcomes, especially in...
TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.
TAVI interventions for all? From congenital bicuspid valve towards valve-in-valve challenging cases
21 May 2026 – From EuroPCR 2026
This session delves into the complexities of TAVI interventions across diverse challenging cases, including congenital bicuspid valves and valve-in-valve scenarios. It emphasizes complication prevention, decision-making for the Unicorn technique, and the critical role of pre-procedural imaging, illustrated through detailed case studies from Estonia, the Netherlands, and...
TAVI - Procedural strategy
21 May 2026 – From EuroPCR 2026
This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in...
Antithrombotic strategies in challenging clininal scenarios
21 May 2026 – From EuroPCR 2026
This session presents a comprehensive overview of antithrombotic strategies tailored to challenging clinical scenarios. Topics include management in elderly patients with atrial fibrillation undergoing DES implantation, the use of low-dose Cangrelor and Bivalirudin during PCI under ECMO in cardiac arrest, polymer types in stents, and timing...
Is DCB the new gold standard for side branch treatment in bifurcation?
21 May 2026 – From EuroPCR 2026
This session explores the emerging role of drug-coated balloons (DCB) as a potential new standard for side branch treatment in bifurcation lesions. It focuses on selecting appropriate indications, optimal vessel preparation and delivery timing, and executing stepwise DCB strategies versus hybrid approaches to maximize clinical outcomes.
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.